×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Mates Sharon

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 29, 2024Option Exercise$12.7335,604453,2391,105,933Aug 30, 2024, 06:01 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 29, 2024Sale$72.5735,6042,583,8841,076,101Aug 30, 2024, 06:01 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 30, 2024Option Exercise$12.7334,396437,8611,104,725Aug 30, 2024, 06:01 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 30, 2024Sale$72.8434,3962,505,3511,076,522Aug 30, 2024, 06:01 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 28, 2024Sale$72.7532,6992,378,8011,070,569Aug 28, 2024, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 26, 2024Option Exercise$17.5722,713399,0671,093,042Aug 28, 2024, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 26, 2024Sale$74.5922,7131,694,2291,070,329Aug 28, 2024, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 27, 2024Option Exercise$17.5740,513711,8131,110,842Aug 28, 2024, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 27, 2024Sale$73.5840,5132,981,0561,087,185Aug 28, 2024, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 28, 2024Option Exercise$17.5732,699574,5211,103,028Aug 28, 2024, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 21, 2024Sale$75.6553,0134,010,5011,079,208Aug 23, 2024, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 22, 2024Option Exercise$17.5739,380691,9071,109,709Aug 23, 2024, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 22, 2024Sale$74.6839,3802,940,8021,074,698Aug 23, 2024, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 23, 2024Option Exercise$17.5728,680503,9081,099,009Aug 23, 2024, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 23, 2024Sale$74.4628,6802,135,4351,070,329Aug 23, 2024, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOAug 21, 2024Option Exercise$17.5753,013931,4381,123,342Aug 23, 2024, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman and CEOApr 24, 2024Option Exercise$17.2620,020345,6181,070,329Apr 25, 2024, 05:08 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOMar 07, 2024Sale$66.5040,7122,707,2771,059,063Mar 11, 2024, 08:33 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOMar 11, 2024Sale$65.2120,5651,341,1231,056,333Mar 11, 2024, 08:33 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOFeb 26, 2024Sale$69.7922,5901,576,4641,072,299Feb 27, 2024, 07:59 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOFeb 02, 2024Sale$67.0733,8852,272,6931,067,759Feb 05, 2024, 06:10 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 17, 2024Option Exercise$16.8648,084810,6961,098,393Jan 18, 2024, 07:47 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 17, 2024Sale$66.2448,0843,185,0621,067,760Jan 18, 2024, 07:47 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 18, 2024Option Exercise$16.8667,9171,145,0811,118,226Jan 18, 2024, 07:47 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 18, 2024Sale$65.1967,9174,427,8491,050,629Jan 18, 2024, 07:47 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 16, 2024Option Exercise$16.8675,3611,270,5871,125,670Jan 18, 2024, 07:47 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 16, 2024Sale$67.2575,3615,067,9821,122,170Jan 18, 2024, 07:47 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOSep 18, 2023Sale$53.7655,5872,988,2131,122,841Sep 19, 2023, 08:40 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOSep 19, 2023Sale$54.1744,4132,405,8521,050,309Sep 19, 2023, 08:40 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOMar 13, 2023Option Exercise$3.2620,00065,2001,150,309Mar 13, 2023, 07:31 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOMar 13, 2023Sale$44.9920,565925,2751,131,721Mar 13, 2023, 07:31 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOMar 10, 2023Sale$43.1541,7701,802,5661,137,114Mar 13, 2023, 07:31 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOFeb 24, 2023Option Exercise$3.2630,00097,8001,130,309Feb 27, 2023, 07:59 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOFeb 24, 2023Sale$47.0322,5901,062,4081,100,309Feb 27, 2023, 07:59 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOFeb 21, 2023Sale$46.8327,8481,304,0001,105,262Feb 22, 2023, 08:01 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEODec 13, 2022Sale$55.0033,0831,819,5651,100,309Dec 15, 2022, 07:01 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOMar 09, 2022Option Exercise$2.8438,925110,5471,133,392Mar 10, 2022, 04:13 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOFeb 24, 2022Sale$51.9822,5891,174,0741,105,807Feb 25, 2022, 07:01 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOFeb 22, 2022Sale$55.3927,8471,542,4131,107,134Feb 23, 2022, 07:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 10, 2022Sale$40.7841,8961,708,4291,130,559Jan 11, 2022, 08:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOOct 18, 2021Sale$40.008,192327,6801,094,467Oct 18, 2021, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOOct 14, 2021Sale$40.001,41656,6401,141,976Oct 18, 2021, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOOct 15, 2021Option Exercise$2.841,0753,0531,102,659Oct 18, 2021, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOOct 15, 2021Sale$40.0040,3921,615,6801,101,584Oct 18, 2021, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOAug 23, 2021Option Exercise$2.8410,00028,4001,143,392Aug 24, 2021, 04:06 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOFeb 19, 2021Sale$39.2327,8471,092,4361,136,492Feb 22, 2021, 08:01 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 11, 2021Sale$32.0141,8961,341,2601,137,977Jan 12, 2021, 07:01 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 04, 2021Sale$31.3048,3411,513,2711,153,820Jan 05, 2021, 06:09 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEODec 18, 2020Option Exercise$2.7434,00093,1601,147,392Dec 21, 2020, 04:03 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEONov 10, 2020Sale$26.3450,0001,317,1011,132,523Nov 12, 2020, 05:51 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEONov 04, 2020Sale$25.0050,0001,250,0001,163,392Nov 06, 2020, 06:00 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 24, 2020Option Exercise$23.619,323220,1161,213,392Jan 28, 2020, 09:28 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 09, 2020Sale$26.1641,8951,095,9731,204,707Jan 10, 2020, 09:09 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 06, 2020Sale$30.2845,5981,380,8801,182,366Jan 08, 2020, 09:11 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 08, 2020Option Exercise$2.7460,000164,4001,246,602Jan 08, 2020, 09:11 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEODec 31, 2019Option Exercise$2.746,00016,4401,162,185Jan 03, 2020, 09:14 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 02, 2020Sale$32.4517,478567,2301,158,485Jan 03, 2020, 09:14 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 04, 2019Sale$11.4545,598522,2221,152,850Jan 08, 2019, 09:28 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 07, 2019Sale$12.436,60482,0881,138,707Jan 08, 2019, 09:28 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 02, 2019Sale$11.0917,478193,8311,138,707Jan 03, 2019, 09:02 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEODec 10, 2018Option Exercise$1.5050,00075,0001,138,707Dec 11, 2018, 05:55 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 08, 2018Sale$17.486,604115,4381,088,707Jan 10, 2018, 09:01 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 05, 2018Sale$17.0811,257192,2701,095,311Jan 05, 2018, 08:19 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOOct 30, 2017Option Exercise$1.5018,75028,1251,107,457Nov 01, 2017, 08:04 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOOct 30, 2017Sale$15.7518,750295,3131,088,707Nov 01, 2017, 08:04 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEOJan 05, 2017Sale$16.554,08167,5411,088,707Jan 09, 2017, 05:31 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEODec 11, 2015Option Exercise$1.1268,75077,1251,137,685Dec 15, 2015, 08:27 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEODec 11, 2015Sale$53.8751,5002,774,4411,107,639Dec 15, 2015, 08:27 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEONov 25, 2014Option Exercise$0.5050,00025,0001,103,935Nov 28, 2014, 04:31 PM
ITCIIntra-Cellular Therapies, Inc.Mates SharonChairman, President & CEONov 28, 2014Sale$14.7535,000516,2501,068,935Nov 28, 2014, 04:31 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe